Skip to main content
. 2016 Jan 13;6:5. doi: 10.1186/s13613-016-0105-0

Table 2.

Primary and secondary outcomes

All (n = 998) ‘High CRP’ (n = 375) ‘Low CRP’ (n = 623) p value
Readmission (%) 9.5 13.1 7.4 0.003
In-hospital mortality (%) 5.5 6.9 4.7 0.127
Adverse outcome (%) 13.4 17.9 10.1 0.001
CRP discharge (mg/L) 58 [33–102] 115 [93–161] 39 [19–55] <0.001
WCC discharge (×109) 12.4 (5.7) 13.3 (5.7) 11.9 (5.6) <0.001
Temp discharge (°C) 37.1 (1.3) 37.2 (1.1) 37.0 (1.4) 0.068
SOFA score discharge 3.0 (1.8) 3.3 (1.9) 2.9 (1.7) <0.001
LOS ICU (days) 7 [5–12] 6 [4–8] 9 [6–16] <0.001
Mechanical ventilation (%) 94 95 93 0.233
Days of mechanical ventilation (n) 3 [1–6] 2 [1–4] 4 [1–7] <0.001
Renal support (%) 14 9 17 <0.001
Destination (%)
 Ward 96 99 95
 Home 1 0 1 0.004
 Nursing/rehabilitation center 3 1 4
LOS hospital after ICU discharge (days) 9 [5–16] 9 [6–16] 9 [5–16] 0.404

Data are presented as mean ± SD (normal distribution), as median with interquartile range (non-normal distribution) or as % (categorical variable)

CRP C-reactive protein; high CRP, CRP ≥75 mg/L; low CRP, CRP <75 mg/L; adverse outcome, intensive care unit readmission and/or in-hospital mortality; WCC white cell counts; Temp body temperature; SOFA Sequential Organ Failure Assessment; LOS length of stay; ICU intensive care unit